NCT04058639 Diabetic Foot Ulcers: Shorter Treatment Period Using Custom Felt Relief?
| NCT ID | NCT04058639 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Helse Møre og Romsdal HF |
| Condition | Diabetic Foot Ulcer |
| Study Type | INTERVENTIONAL |
| Enrollment | 74 participants |
| Start Date | 2019-10-01 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 74 participants in total. It began in 2019-10-01 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Surgical Outpatient Clinic at Molde Hospital has since 2015 offered specialized treatment for patients with diabetic foot ulcers. This treatment is given by an interdisciplinary diabetic foot ulcer team. The standard treatment for diabetic foot ulcers is relief, a method with good results. Although the treatment as usual gives good results, the team wants to optimize this treatment. By using custom felt relief for each patient, the treatment period might be reduced considerably. The aim of this study is therefore to investigate whether custom felt relief gives shorter processing time compared to standard relief treatment.
Eligibility Criteria
Inclusion Criteria: * diagnosed with Diabetes Mellitus Type 1 or 2 * has neuropathic wounds under the foot * understands and speaks Norwegian well * competent to give consent Exclusion Criteria: * responds to the filament glue and/or the tape used in treatment * in need of vascular surgery intervention * to be admitted to the hospital * in need of intravenously administered antibiotics due to wound infection.
Contact & Investigator
Tone Seim Fuglset, phd
STUDY DIRECTOR
Helse Møre og Romsdal HF
Frequently Asked Questions
Who can join the NCT04058639 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 80 Years, studying Diabetic Foot Ulcer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04058639 currently recruiting?
Yes, NCT04058639 is actively recruiting participants. Contact the research team at Ida.Gule@helse-mr.no for enrollment information.
Where is the NCT04058639 trial being conducted?
This trial is being conducted at Molde, Norway.
Who is sponsoring the NCT04058639 clinical trial?
NCT04058639 is sponsored by Helse Møre og Romsdal HF. The principal investigator is Tone Seim Fuglset, phd at Helse Møre og Romsdal HF. The trial plans to enroll 74 participants.